The prevalence of systemic autoimmune rheumatic diseases in Canadian pediatric populations:

Download
File Size75.0 KiB
DateNovember 12, 2014
Downloads794
AuthorNatalie Jane Shiff, Lisa M. Lix, Lawrence Joseph, Ciaran Duffy, Lori B. Tucker, Lawrence W. Svenson, Patrick Belisle , Sasha Bernatsky
PUB MED Information on article. Can access it through your institution.

1. Rheumatol Int. 2014 Sep 26. [Epub ahead of print]

The prevalence of systemic autoimmune rheumatic diseases in Canadian pediatric populations: administrative database estimates.

Shiff NJ(1), Lix LM, Joseph L, Duffy C, Tucker LB, Svenson LW, Belisle P, Bernatsky S.

Author information:
(1)Department of Paediatrics, Royal University Hospital, University of Saskatchewan, 103 Hospital Drive, Saskatoon, SK, S7N 0W8, Canada, [email protected]

To estimate systemic autoimmune rheumatic disease (SARD) prevalence using administrative data for pediatric populations in four Canadian provinces. Physician billing claims and inpatient hospitalizations from Alberta, Manitoba,
Quebec, and Saskatchewan were used to define cases aged ≤18 years with a SARD diagnosis code in: one or more hospitalization, two or more physician visits within 2 years and at least 2 months apart, or one or more physician visit to a rheumatologist. Estimates ranged from 15.9/100,000 in Quebec [95 % confidence interval (95 % CI) 14.1, 18.0] to 23.0/100,000 in Manitoba (95 % CI 17.9, 29.2). SARDs were more common in females than in males across all provinces. There was a slightly higher prevalence among those living in urban compared to rural areas of Alberta (rate difference 14.4, 95 % CI 8.6, 20.1) and Saskatchewan (rate difference 13.8, 95 % CI 1.0, 26.6). Our results provide population-based
prevalence estimates of pediatric SARDs in four Canadian provinces.

PMID: 25257764 [PubMed - as supplied by publisher]